Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis
Authors
Jonathan I. Silverberg (ORCID: https://orcid.org/0000-0003-3686-7805)
Marjolein S. de Bruin-Weller (ORCID: https://orcid.org/0000-0002-1249-6993)
Wan‐Ju Lee (ORCID: https://orcid.org/0000-0001-9263-6943)
Eric L. Simpson (ORCID: https://orcid.org/0000-0003-0853-0252)
Henrique D. Teixeira (ORCID: https://orcid.org/0000-0001-5488-3556)
Emma Guttman‐Yassky (ORCID: https://orcid.org/0000-0002-9363-324X)
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis
Jonathan I. Silverberg, Marjolein S. de Bruin-Weller, Wan‐Ju Lee, Eric L. Simpson et al.
Citations
3 citations
Journal
Dermatology and Therapy
Topics
Dermatology and Skin Diseases
Field-Weighted Citation Impact (FWCI)
6.01
article
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis
Jonathan I. Silverberg, Marjolein S. de Bruin-Weller, Wan‐Ju Lee, Eric L. Simpson, Henrique D. Teixeira, Emma Guttman‐Yassky, Namita Vigna, Norito Katoh, Brian Calimlim, Cristina Sancho Sanchez, Mark Boguniewicz, Eingun James Song, Vimal H. Prajapati, Tianshuang Wu, Kilian Eyerich
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Dermatology and TherapyVol. 15(8)
Institutions
University of Freiburg (DE), Oregon Health & Science University (US), University of Calgary (CA), Kyoto Prefectural University (JP), George Washington University (US), Utrecht University (NL), University Medical Center Freiburg (DE), AbbVie (United States) (US), National Jewish Health (US), Kyoto Prefectural University of Medicine (JP), SKiN Health (CA), Probity Medical Research (CA), University of Colorado Denver (US), Icahn School of Medicine at Mount Sinai (US)